Genetic markers of increased susceptibility to diabetic nephropathy

被引:9
作者
Doria, A
机构
[1] Joslin Diabet Ctr, Sect Epidemiol & Genet, Div Res, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
关键词
insulin-dependent diabetes mellitus; diabetic nephropathy; angiotensinogen; angiotensin I-converting enzyme; angiotensin II receptor; aldose reductase; DNA polymorphisms; genetics;
D O I
10.1159/000053095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of exposure to diabetes on the kidney appears to be modulated by genetic factors determining a variable degree of susceptibility to diabetic nephropathy. Multiple loci are probably involved. Some of them might be found among the genes coding for components of the renin angiotensin system (renin, angiotensinogen, angiotensin I-converting enzyme, angiotensin receptors), some may regulate the way in which cells manage hyperglycemia (e.g. aldose reductase). Various genes have been examined to date, mainly by means of association studies. Positive results have been found for some of them (e.g. ACE, AGTR1, aldose reductase), but have not been confirmed in other populations. Thus, no genetic marker of increased susceptibility to diabetic nephropathy having clinical utility is currently available. New insights are expected from the systematic scanning of the genome for linkage with diabetic nephrophathy.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 31 条
[11]   Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM [J].
Doria, A ;
Onuma, T ;
Warram, JH ;
Krolewski, AS .
DIABETOLOGIA, 1997, 40 (11) :1293-1299
[12]   A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM [J].
Fogarty, DG ;
Harron, JC ;
Hughes, AE ;
Nevin, NC ;
Doherty, CC ;
Maxwell, AP .
DIABETES, 1996, 45 (09) :1204-1208
[13]   Polymorphism in the 5'-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes [J].
Heesom, AE ;
Hibberd, ML ;
Millward, A ;
Demaine, AG .
DIABETES, 1997, 46 (02) :287-291
[14]  
INOUE U, 1997, J CLIN INVEST, V99, P1786
[15]   MOLECULAR-BASIS OF HUMAN HYPERTENSION - ROLE OF ANGIOTENSINOGEN [J].
JEUNEMAITRE, X ;
SOUBRIER, F ;
KOTELEVTSEV, YV ;
LIFTON, RP ;
WILLIAMS, CS ;
CHARRU, A ;
HUNT, SC ;
HOPKINS, PN ;
WILLIAMS, RR ;
LALOUEL, JM ;
CORVOL, P .
CELL, 1992, 71 (01) :169-180
[16]   MAGNITUDE AND DETERMINANTS OF CORONARY-ARTERY DISEASE IN JUVENILE-ONSET, INSULIN-DEPENDENT DIABETES-MELLITUS [J].
KROLEWSKI, AS ;
KOSINSKI, EJ ;
WARRAM, JH ;
LELAND, OS ;
BUSICK, EJ ;
ASMAL, AC ;
RAND, LI ;
CHRISTLIEB, AR ;
BRADLEY, RF ;
KAHN, CR .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (08) :750-755
[17]  
KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1252
[18]  
KROLEWSKI AS, 1994, JOSLINS DIABETES MEL
[19]   THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY [J].
LEWIS, EJ ;
HUNSICKER, LG ;
BAIN, RP ;
ROHDE, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) :1456-1462
[20]   RELATIONSHIPS BETWEEN ANGIOTENSIN-I CONVERTING-ENZYME GENE POLYMORPHISM, PLASMA-LEVELS, AND DIABETIC RETINAL AND RENAL COMPLICATIONS [J].
MARRE, M ;
BERNADET, P ;
GALLOIS, Y ;
SAVAGNER, F ;
GUYENE, TT ;
HALLAB, M ;
CAMBIEN, F ;
PASSA, P ;
ALHENCGELAS, F .
DIABETES, 1994, 43 (03) :384-388